Online Medical Classes

Home > American Association For Medical Transcription Information > American Association For Medical Transcription News

American Association For Medical Transcription News

  • West metro briefs: Music in Plymouth celebration Wednesday, June 29, 2011 @ 12:10AMThe Minnesota Orchestra will headline an array of talent at the Music in Plymouth celebration that begins at 5 p.m. today at the Hilde Performance Center, 3500 Plymouth Blvd. in Plymouth.
  • Weill Cornell Investigative Drug Shuts Down Aggressive Form Of Leukemia That Affects Children Tuesday, May 24, 2011 @ 4:20AMIn a significant breakthrough, investigators at Weill Cornell Medical College and the University of California, San Francisco, have been able to overcome resistance of a form of leukemia to targeted therapy, demonstrating complete eradication of the cancer in cell and animal studies...
  • New highly efficient way to make reprogrammed stem cells Friday, April 8, 2011 @ 10:25AMResearchers have devised a totally new and far more efficient way of generating induced pluripotent stem cells (iPSCs), immature cells that are able to develop into several different types of cells or tissues in the body. The researchers used fibroblast cells, which are easily obtained from skin biopsies, and could be used to generate patient-specific iPSCs for drug screening and tissue ...
  • An international study in China finds strawberries may slow precancerous growth in the esophagus Wednesday, April 6, 2011 @ 8:35AMEating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and researchers in China.
  • Strawberries may slow precancerous growth in the esophagus, study suggests Wednesday, April 6, 2011 @ 8:25AMEating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study.
  • AACR Elects President-Elect, Directors and Nominating Committee Members Tuesday, March 22, 2011 @ 10:24AMThe members of the American Association for Cancer Research have elected Frank McCormick, Ph.D., D.Sc. (hon.), as their president-elect. McCormick is the director of the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. He holds the E. Dixon Heise distinguished professorship in oncology and the David A. Wood distinguished professorship of tumor ...
  • Lycera Announces Research Collaboration With Merck To Discover, Develop And Commercialize Drugs For Autoimmune Diseases Monday, March 7, 2011 @ 7:43AMLycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has entered into an exclusive research collaboration with Merck to discover, develop and commercialize small molecules that target T-helper 17 (Th17) cells, key mediators of inflammation. The collaboration will focus on ...
  • Lycera Announces Research Collaboration with Merck to Discover, Develop and Commercialize Drugs for Autoimmune Diseases Thursday, March 3, 2011 @ 7:30AMLycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has entered into an exclusive research collaboration with Merck to discover, develop and commercialize small molecules that target T-helper 17 cells, key mediators of inflammation.
  • SOC presents national stroke study data at 2011 International Stroke Conference Monday, February 14, 2011 @ 3:17AMSpecialists On Call, the nation's leading provider of clinical telemedicine services, announced today that it has presented data from a national stroke study conducted in partnership with the University of California at Los Angeles at the American Heart Association and American Stroke Association's International Stroke Conference.
  • Stimulus funds help wire rural homes for the Internet Saturday, January 29, 2011 @ 3:45PMEAST BURKE, Vt. - Up in rural northern Vermont, it took until the 1960 s to run power lines to some towns – decades after the rest of America got turned on.
  • Eight with ties to La Jolla named as AAAS Fellows Monday, January 17, 2011 @ 1:29PMSeven UCSD professors and a Salk Institute researcher have been named new Fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society..
  • Peers Elect MD Anderson's Hung and Lozano as Fellows of AAAS Wednesday, January 12, 2011 @ 8:31AMInnovative insights into a vital tumor-suppressing mechanism that is often broken in malignant cells and a type of receptor protein that frequently goes haywire to stimulate cancer growth have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a distinguished association of scholars.
  • Winners Of 2011 International Travel Awards Announced By Biophysical Society Monday, January 3, 2011 @ 5:31AMThe Biophysical Society has announced the winners of its international travel grants to attend the Biophysical Society's 55th Annual Meeting at the Baltimore Convention Center in Baltimore, Maryland, March 5-9, 2011. The purpose of these awards is to foster and initiate further interaction between American biophysicists and scientists working in countries experiencing financial difficulties ...
  • Most common adult brain cancer linked to gene deletion, Stanford doctors say Wednesday, December 22, 2010 @ 4:28PM( Stanford University Medical Center ) A study fast-tracked for online publication Dec. 22 in the New England Journal of Medicine has identified an important gene deletion in up to one of every four cases of glioblastoma, the most common adult brain cancer. This deletion contributes to tumor development, promotes resistance to therapy and considerably worsens a patient's survival prospects.
  • Sperm Stem Cells Turned Into Insulin-Producing Cells Monday, December 13, 2010 @ 7:24AMUsing sperm stem cells to make pancreatic beta insulin-producing cells could one day form the basis of a safe treatment for type 1 diabetes in men with the disease, and there is no reason why a similar treatment based on egg stem cells should not be feasible for women with the disease, scientists told a conference in the US on Sunday. Dr G...
  • Insulin-secreting pancreatic islet cells from SSCs Monday, December 13, 2010 @ 1:04AMInsulin-secreting pancreatic islet cells have been generated from human spermatogonial stem cells (SSCs) directly isolated from human testicular tissue, researchers reported today at the American Association of Cell Biology 50th Annual Meeting in Philadelphia.
  • Digestive Disease Specialists deploys Wolters Kluwer Health's ProVation MD software Thursday, December 9, 2010 @ 4:25AMWolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Digestive Disease Specialists, Inc. has selected its ProVation MD software for gastroenterology procedure documentation and coding.
  • Life in high-definition: New microscopy technique earns top prize for young life scientists Thursday, December 2, 2010 @ 1:27PM( American Association for the Advancement of Science ) For his novel research to obtain high-resolution images of biological cells and tissues, Mark Bates has been named the 2010 Grand Prize winner for the GE & Science Prize for Young Life Scientists. The annual competition, which includes a grand-prize award of $25,000, is supported by GE Healthcare and the journal Science, which is published ...
  • What's Next In CVD Research? Research Roundtable Thursday, November 18, 2010 @ 7:23AMYears of research are the basis for the latest drugs and treatments for cardiovascular disease. This discussion highlighted early and pre-clinical research that may well be the foundation of treatments to come. Abstract 21739 - Researchers discover genetic material involved in regulating HDL A sequence of genetic material called miR-33a helps keep high-density lipoprotein (HDL, the "good ...
  • K. T. Li Technology and Literature Lectureship Announced Winners of Awards Tuesday, November 9, 2010 @ 5:17AMTAINAN, Taiwan--(BUSINESS WIRE)--K. T. Li Technology and Literature Lectureship Announced Winners of Awards
  • K. T. Li Technology and Literature Lectureship Announced Winners of Awards Tuesday, November 9, 2010 @ 5:04AMThe K. T. Li Technology and Literature Lectureship has announced the winners of its Chair Professor Award, Research Award, Gold Medal Award and Honorary Scholar on November 9th in Library of National Cheng Kung University , Tainan, Taiwan.
  • Exempla Healthcare Selects ProVation Medical Software for Procedure Documentation and Coding at Multiple Facilities Monday, November 8, 2010 @ 8:33AMMINNEAPOLIS--(BUSINESS WIRE)--Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Exempla Healthcare has selected its ProVation® MD software for gastroenterology and pulmonary procedure documentation and coding. ProVation MD will be deployed across three hospitals in the nationally recognized Exempla Healthcare System ...
  • Exempla Healthcare Selects ProVation Medical Software for Procedure Documentation and Coding at Multiple Facilities Monday, November 8, 2010 @ 8:23AMWolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Exempla Healthcare has selected its ProVation® MD software for gastroenterology and pulmonary procedure documentation and coding.
  • Press Release Monday, November 8, 2010 @ 4:32AMGenentech Inc. Posted on:08 Nov 10 Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA® (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
  • Study finds bortezomib to be promising treatment for rheumatoid arthritis Wednesday, November 3, 2010 @ 9:32AM( Wiley-Blackwell ) A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and ...
  • RainDance’s Targeted Sequencing Approach Powers Three Groundbreaking Human Genetic Studies Tuesday, November 2, 2010 @ 7:16AMWASHINGTON--(BUSINESS WIRE)--Scientists from Leading Institutions to Present Data Demonstrating Impact of RainDance Technology in Organ Transplantation, Alzheimer’s, Autism and X-linked Mental Retardation Research at ASHG meeting
  • RainDance’s Targeted Sequencing Approach Powers Three Groundbreaking Human Genetic Studies Tuesday, November 2, 2010 @ 7:00AMRainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single-molecule and single-cell analysis, today announced that scientists from The Scripps Research Institute, the Translational Genomics Research Institute and Emory University will present data highlighting the broad utility of the company’s innovative microdroplet platform during the 60th Annual ...
  • Epigenomics discovery yields new information about fat cells Thursday, September 30, 2010 @ 6:21PMBy creating a "map" of histone modifications in fat cells, investigators have discovered two new factors that regulate fat formation, a key step on the road to better understanding obesity, diabetes and other metabolic disorders.
  • Oakton Briefs Monday, September 27, 2010 @ 11:53AMProspective students and their families are invited to visit Oakton Community College's Des Plaines campus, 1600 E. Golf Road, starting at 10 a.m. Oct. 11.
  • Researchers Develop Database to Help Accelerate Drug Discovery Wednesday, September 15, 2010 @ 8:37AMResearchers from Mount Sinai School of Medicine have developed a new computational method that will help streamline the analysis of gene expression experiments and provide scientists with a better mechanistic understanding of the differences between diseased and normal cells.
  • Gene Involved In Fuchs Corneal Dystrophy Is Found Thursday, August 26, 2010 @ 7:33AMA 13-member research team led by University of Oregon scientist Dr. Albert O. Edwards has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations. Edwards performed a genome-wide analysis comparing patients with and without typical age-related Fuchs, finding an alteration in the transcription-factor-4 gene ...
  • Gene involved in Fuchs corneal dystrophy is found Thursday, August 26, 2010 @ 12:14AMA research team has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations.
  • Gene Involved in Fuchs Corneal Dystrophy Is Found Wednesday, August 25, 2010 @ 5:25PMA 13-member research team led by a University of Oregon medical scientist has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations.
  • Gene involved in Fuchs corneal dystrophy is found Wednesday, August 25, 2010 @ 4:31PMA 13-member research team led by University of Oregon scientist Dr. Albert O. Edwards has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operations.
  • Genome Scanning Finds Genes For Cholesterol And Heart Disease That Could Be Important Targets For Treatment Thursday, August 5, 2010 @ 7:20AMTwo international studies published in a leading journal this week have pinpointed genes for cholesterol and heart disease that could be important targets for treatment, and demonstrate the potential clinical value of "genome scanning" or GWAS, genome wide association studies, in developing new diagnostic tests and therapies for diseases with genetic risks...
  • Alnylam Scientists Contribute to Discovery of a New Disease Gene in Cardiovascular Disease Thursday, August 5, 2010 @ 7:12AMCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at ...
  • Alnylam Scientists Contribute to Discovery of a New Disease Gene in Cardiovascular Disease Thursday, August 5, 2010 @ 7:00AMCAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction .
  • Boston court deals 2 blows to Defense of Marriage Act Friday, July 9, 2010 @ 2:10AMA U.S. judge in Boston has ruled that a federal gay-marriage ban is unconstitutional because it interferes with the right of a ...
  • Gay marriage ban struck down Friday, July 9, 2010 @ 12:11AMboston Judge: Federal law is unconstitutional The federal law banning gay marriage is unconstitutional because it interferes with the right of a state to define the institution and therefore denies married gay couples some federal benefits, a federal judge ruled yesterday in Boston. U.S. District Judge Joseph Tauro ruled in favor of gay couples' rights in two separate challenges to the Defense ...
  • A-Life Medical, Inc. Expands Growing Network of Professionals with New Appointments and Promotion Monday, June 28, 2010 @ 4:00AMSAN DIEGO----A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today that it has named three new directors and promoted its engineering manager, all in an effort to fuel the company’s continued, rapid growth.
  • Epigenetic Gene Silencing May Hold Key To Fatal Lung Vascular Disease Tuesday, June 8, 2010 @ 6:27AMA rare but fatal disease of blood vessels in the lung may be caused in part by aberrant silencing of genes rather than genetic mutation, new research reports. Pulmonary arterial hypertension, a syndrome characterized by gradual blockage of blood vessels in the lungs, has been linked to genetic causes in a small percentage of patients. But University of Chicago researchers have now found that a ...
  • Death star Wednesday, May 26, 2010 @ 12:35PMA fax that Michael Hengartner sent to his mentor helped turn apoptosis into a Nobel Prize-winning pathway
  • Androgen receptors promote hepatitis B virus in growth and development of hepatoma cells Thursday, May 20, 2010 @ 5:25AMDr. Ming-Heng Wu of the Institute of Basic Medical Sciences at National Cheng Kung University (NCKU), Taiwan, in collaboration with Prof. Chawnshang Chang's laboratory of University of Rochester (UR), United States, have discovered that androgen receptors (AR) can promote hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus (HBV) RNA transcription.
  • Cutting-Edge Research Presented During Digestive Disease Week Tuesday, May 4, 2010 @ 7:28AMClinicians, researchers and scientists from around the world will gather for Digestive Disease Week® 2010 (DDW), the largest and most prestigious gastroenterology meeting, from May 1 to May 5, 2010, at the Ernest N. Morial Convention Center, New Orleans, LA. DDW is the annual meeting of the American Gastroenterological Association (AGA) Institute, the largest and oldest GI society in the world ...
  • Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified Thursday, April 22, 2010 @ 5:06AMA new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.
  • Cyclacel's Innovative and Diverse Oncology Targeted Pipeline Highlighted in Six Presentations at AACR Annual Meeting Tuesday, April 20, 2010 @ 1:00PMBERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. , a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced the presentation of preclinical results for several of its pipeline compounds during the American Association of Cancer Research 101st Annual Meeting 2010 in ...
  • NanoString Technologies launches new miRNA assay kits Tuesday, April 20, 2010 @ 3:53AMNanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the ...
  • Radiolabeled hedgehog can differentiate stem-like cancer cells and identify aggressive tumors Monday, April 19, 2010 @ 4:18AMAt the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.
  • Idera Pharmaceuticals Announces Positive Phase 1 Data of IMO-2125 in Null Responder HCV Patients at EASL 2010 Thursday, April 15, 2010 @ 10:30AMCAMBRIDGE, Mass.----Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 agonist, in null responder patients with chronic hepatitis C virus infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver .
  • Dolbey Completes Phase One of Fusion CAC Implementation at Adventist Health System Tuesday, April 13, 2010 @ 3:44PMWASHINGTON----Today at the American Health Information Management Association’s Computer-Assisted Coding Summit, Dolbey announced that it has completed, along with Artificial Medical Intelligence, the first phase of its Fusion CAC™ implementation at Adventist Health System in Orlando, Florida.